HKD 0.13
(-3.82%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -804 Million | 200 Million | 558 Million | -118 Million | 362 Million | -1.11 Billion |
Net Income | -2.33 Billion | -664 Million | 381 Million | -1.74 Billion | -3.49 Billion | -2.14 Billion |
Depreciation & Amortization | 697 Million | 714 Million | 704 Million | 238 Million | 1.36 Billion | 455 Million |
Deferred income taxes | - | - | -1.96 Billion | -203 Million | 1.52 Billion | -326 Million |
Stock-based compensation | - | - | -11 Million | 3 Million | 7 Million | -5 Million |
Change in working capital | 145 Million | 411 Million | -563 Million | 349 Million | 916 Million | 331 Million |
Other non-cash items | 2.76 Billion | -261 Million | 2 Billion | 1.23 Billion | 46 Million | 575 Million |
Investing Cash Flow | -134 Million | -88 Million | -37 Million | 139 Million | 33 Million | 427 Million |
Investments in PPE | -101 Million | -86 Million | -45 Million | -8 Million | -115 Million | -163 Million |
Acquisitions | 2 Million | 1 Million | 8 Million | 85 Million | - | 5 Million |
Investment purchases | -49 Million | -3 Million | -13 Million | - | - | -536 Million |
Sales/Maturities of investments | - | -3 Million | 4 Million | 56 Million | 54 Million | 531 Million |
Other Investing Activities | -33 Million | 3 Million | 9 Million | 6 Million | 94 Million | 590 Million |
Financing Cash Flow | -658 Million | -669 Million | -29 Million | -152 Million | -1.31 Billion | - |
Debt repayment | -658 Million | -669 Million | -9 Million | -1.31 Billion | -8 Million | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 695 Million | - | - | - |
Other Financing Activities | -658 Million | -673 Million | -715 Million | 529 Million | - | - |
Accounts receivables | 10 Million | 557 Million | 239 Million | -228 Million | - | -120 Million |
Accounts payables | -299 Million | 21 Million | -694 Million | 542 Million | - | -763 Million |
Inventory | 411 Million | -68 Million | -110 Million | -38 Million | 580 Million | 451 Million |
Other working capital | 23 Million | -99 Million | 2 Million | 73 Million | 336 Million | 763 Million |
Cash at beginning of period | 2.01 Billion | 2.64 Billion | 2.27 Billion | 3.17 Billion | 3.17 Billion | 3.87 Billion |
Cash at end of period | 434 Million | 2.01 Billion | 2.64 Billion | 2.27 Billion | 2.23 Billion | 3.17 Billion |
Capital Expenditure | -101 Million | -86 Million | -45 Million | -8 Million | -115 Million | -163 Million |
Effect of forex changes on cash | 19 Million | -80 Million | -114 Million | 172 Million | -17 Million | -21 Million |
Net cash flow / Change in cash | -1.57 Billion | -637 Million | 378 Million | -901 Million | -940 Million | -708 Million |
Free Cash Flow | -905 Million | 114 Million | 513 Million | -126 Million | 247 Million | -1.27 Billion |
Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -56 Million | -2.33 Billion | -1.62 Billion | -714 Million | -664 Million | -677 Million |
Depreciation & Amortization | 201 Million | 697 Million | 326 Million | 357 Million | 714 Million | 350 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 145 Million | 421 Million | - | 411 Million | 489 Million |
Other non-cash items | 3 Million | 2.76 Billion | 363 Million | 791 Million | -261 Million | 1.06 Billion |
Investing Cash Flow | -297 Million | -134 Million | -74 Million | -69 Million | -88 Million | -28 Million |
Investments in PPE | -8 Million | -101 Million | -33 Million | -68 Million | -86 Million | -69 Million |
Acquisitions | -287 Million | 2 Million | 1 Million | 1 Million | 1 Million | 1 Million |
Investment purchases | -3 Million | -49 Million | -47 Million | -2 Million | -3 Million | 40 Million |
Sales/Maturities of investments | 1 Million | - | - | -8 Million | -3 Million | -45 Million |
Other Investing Activities | - | -33 Million | -41 Million | 8 Million | 3 Million | 45 Million |
Financing Cash Flow | -214 Million | -658 Million | -289 Million | -369 Million | -669 Million | -326 Million |
Debt repayment | - | -658 Million | - | -326 Million | -669 Million | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -214 Million | - | -289 Million | -43 Million | -673 Million | -326 Million |
Accounts receivables | - | 10 Million | 10 Million | - | 557 Million | 557 Million |
Accounts payables | - | -299 Million | - | - | 21 Million | - |
Inventory | - | 411 Million | 411 Million | - | -68 Million | -68 Million |
Other working capital | - | 23 Million | - | - | -99 Million | - |
Cash at beginning of period | 434 Million | 2.01 Billion | 1.31 Billion | 2.01 Billion | 2.64 Billion | 2.3 Billion |
Cash at end of period | 62 Million | 434 Million | 434 Million | 1.31 Billion | 2.01 Billion | 2.01 Billion |
Capital Expenditure | -8 Million | -101 Million | -33 Million | -68 Million | -86 Million | -69 Million |
Effect of forex changes on cash | - | 19 Million | -1 Million | 20 Million | -80 Million | 21 Million |
Net cash flow / Change in cash | -372 Million | -1.57 Billion | -879 Million | -698 Million | -637 Million | -291 Million |
Free Cash Flow | 140 Million | -905 Million | -548 Million | -348 Million | 114 Million | -27 Million |
GTPL
SHILPAMED
PACT
6940
AMDIND
NBRI